Sangeeta N. Bhatia - 08 Aug 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
Director
Signature
/s/ Joy Liu, Attorney-in-Fact
Issuer symbol
VRTX
Transactions as of
08 Aug 2022
Net transactions value
-$181,972
Form type
4
Filing time
10 Aug 2022, 16:07:29 UTC
Previous filing
02 Aug 2022
Next filing
26 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Sale $13,058 -45 -0.85% $290.18 5,237 08 Aug 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale $47,849 -164 -3.1% $291.76 5,073 08 Aug 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale $59,803 -204 -4% $293.15 4,869 08 Aug 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale $47,373 -161 -3.3% $294.24 4,708 08 Aug 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale $13,890 -47 -1% $295.53 4,661 08 Aug 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Dr. Bhatia's company approved trading plan under Rule 10b5-1.
F2 Dr. Bhatia undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $290.18 (range $290.05 to $290.20).
F4 Open market sales reported on this line occurred at a weighted average price of $291.76 (range $291.59 to $291.91).
F5 Open market sales reported on this line occurred at a weighted average price of $293.15 (range $292.71 to $293.61).
F6 Open market sales reported on this line occurred at a weighted average price of $294.24 (range $293.85 to $294.49).